Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2021-05-03 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13012), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DES PEINTRES ROUX : revenue, balance sheet and financial ratios
SELARL PHARMACIE DES PEINTRES ROUX is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13012),
this company of category PME
shows in 2025 a net income positive of 146 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DES PEINTRES ROUX (SIREN 897845954)
Indicator
2025
2024
2023
2022
Revenue
N/C
N/C
N/C
N/C
Net income
146 110 €
110 729 €
241 268 €
85 829 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DES PEINTRES ROUX generates positive net income of 146 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 86 k€ -> 146 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
146 110 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 178%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
177.517%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
31.848%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DES PEINTRES ROUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
2024
2025
Debt ratio
406.912
272.387
219.436
177.517
Financial autonomy
17.028
23.619
27.595
31.848
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
177.522025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of SELARL PHARMACIE DES PEIN... (177.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
31.85%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of SELARL PHARMACIE DES PEIN... (31.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 145.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
145.637
Liquidity indicators evolution SELARL PHARMACIE DES PEINTRES ROUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
2024
2025
Liquidity ratio
148.438
160.87
143.758
145.637
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
145.642025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average
In 2025, the liquidity ratio of SELARL PHARMACIE DES PEIN... (145.64) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE DES PEINTRES ROUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DES PEINTRES ROUX is estimated at
2 320 974 €
(range 1 575 024€ - 3 641 928€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1575k€2320k€3641k€
2 320 974 €Range: 1 575 024€ - 3 641 928€
NAF 5 année 2025
Valuation method used
Net Income Multiple
146 110 €
×
15.9x
=2 320 975 €
Range: 1 575 024€ - 3 641 929€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DES PEINTRES ROUX with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DES PEINTRES ROUX
What is the revenue of SELARL PHARMACIE DES PEINTRES ROUX ?
The revenue of SELARL PHARMACIE DES PEINTRES ROUX is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DES PEINTRES ROUX profitable?
Yes, SELARL PHARMACIE DES PEINTRES ROUX generated a net profit of 146 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DES PEINTRES ROUX ?
The headquarters of SELARL PHARMACIE DES PEINTRES ROUX is located in MARSEILLE (13012), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL PHARMACIE DES PEINTRES ROUX ?
The tax return of SELARL PHARMACIE DES PEINTRES ROUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DES PEINTRES ROUX operate?
SELARL PHARMACIE DES PEINTRES ROUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart